Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments

NCT ID: NCT05174949

Last Updated: 2024-07-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-18

Study Completion Date

2023-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke is the leading cause of serious, long-term disability. The emergence of abnormal muscle synergies following a stroke presents a major limitation to the recovery of independent function. Despite the development of many interventions for movement recovery post-stroke, rehabilitation treatments are minimally effective to the muscle synergy impairment. Previous studies have found that muscle synergy impairment is associated with the damage to the corticospinal tract and the maladaptive recruitment of the contralesional cortico-reticulospinal tract. The investigators hypothesize that facilitating the damaged cortico-spinal tract (via primary motor cortex) and/or inhibiting the contralesional cortico-reticulospinal tract (via dorsal premotor cortex) will reduce muscle synergy impairment. In this pilot project, the investigators propose to run a proof-of-concept pilot trial to evaluate the effect of the targeted high-definition transcranial direct current stimulation (HD-tDCS) on mitigating muscle synergy impairment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized, double-blinded, sham-controlled cross-over study will include three stimulation conditions: 1) anodal stimulation over the ipsilesional primary motor cortex, 2) cathodal one over the contralesional premotor cortex, 3) sham stimulation in chronic hemiparetic stroke patients.

Stroke participants (\> 3 months after stroke) with moderate to severe motor impairments (Fugl-Meyer Motor Assessment - Upper Extremity score between 10-40, in absence of clinically defined sensory deficits) and an ischemic unilateral subcortical lesion will receive each type of stimulation for 20 minutes.

Their brain activity and behavior data will be collected for the outcome measures.

The patient time commitment in this study is approximately 7 weeks where subjects have 3 x 1-day intervention and measurements, with 2 weeks washout period in between.

The total number of potential enrolled subjects in this pilot study is 12.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This sham-controlled cross-over study design will include three visits: 1) anodal stimulation targeting ipsilesional primary motor cortex, 2) cathodal one at the contralesional premotor cortex, 3) a sham stimulation visit. The sequence of the stimulations will be randomized and double-blinded. After each intervention, there will be at least 2 weeks wash-out period before participants receive the next intervention and assessments.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham, Anodal, Cathodal

Treatment order 1: Sham, Anodal, Cathodal

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Anodal, Cathodal, Sham

Treatment order 2: Anodal, Cathodal, Sham

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Cathodal, Sham, Anodal

Treatment order 3: Cathodal, Sham, Anodal

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Sham, Cathodal, Anodal

Treatment order 4: Sham, Cathodal, Anodal

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Cathodal, Anodal, Sham

Treatment order 5: Cathodal, Anodal, Sham

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Anodal, Sham, Cathodal

Treatment order 6: Anodal, Sham, Cathodal

Group Type EXPERIMENTAL

Transcranial direct current stimulation (high-definition)

Intervention Type DEVICE

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial direct current stimulation (high-definition)

Three conditions (2 mA, 20 mins):

1. anodal stimulation over the ipsilesional primary motor cortex
2. cathodal one over the contralesional premotor cortex
3. Sham

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ischemic unilateral stroke lesion (confirmed by the most recent clinical or radiological reports) at least 3 months prior to participation in this project.
* Paresis confined to one side, with moderate to severe motor impairment of the upper limb (Fugl-Meyer upper extremity scores of 10-40)
* Capacity to provide informed consent

Exclusion Criteria

* Muscle tone abnormalities and motor or sensory impairment in the unimpaired limb
* Severe wasting or contracture or significant sensory deficits in the paretic upper limb
* Severe cognitive or affective dysfunction that prevents normal communication and understanding of consent or instruction
* Severe concurrent medical problems (e.g. cardiorespiratory impairment)
* Using a pacemaker
* Metal implants in the head
* Known adverse reaction to TMS and tDCS
* Pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oklahoma Shared Clinical and Translational Resources

OTHER

Sponsor Role collaborator

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Williamson J, James SA, Apple B, Sharps J, Sidorov E.V., Yang Y, (2022), High Definition Transcranial Direct Current Stimulation for Improving Upper Extremity Motor Function post Stroke. June 8-10, the 3rd International Workshop on Non-Invasive Brain Stimulation (NIBS) 2022.

Reference Type RESULT

Lepak L.V., Cheema C.F, James S.A., Yang Y (2023), Computer-Guided Non-Invasive High-Definition Transcranial Direct Current Brain Stimulation as a Targeted Intervention after a Stroke, American Physical Therapy Association (APTA) Combined Sections Meeting (CSM), San Diego, CA, Feb 23-25, 2023

Reference Type RESULT

Williamson JN, James SA, He D, Li S, Sidorov EV, Yang Y. High-definition transcranial direct current stimulation for upper extremity rehabilitation in moderate-to-severe ischemic stroke: a pilot study. Front Hum Neurosci. 2023 Oct 12;17:1286238. doi: 10.3389/fnhum.2023.1286238. eCollection 2023.

Reference Type DERIVED
PMID: 37900725 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tDCS and Physical Therapy in Stroke
NCT00542256 COMPLETED NA